From: Type IV fimbrial subunit protein ApfA contributes to protection against porcine pleuropneumonia
Vaccine1 | Number of pigs2 | Clinical score3 | Body temperature (°C)4 | Lung lesion score5 | Re-isolation of the challenge strain (%)6 | Surviving pigs (%) |
---|---|---|---|---|---|---|
rApfA | 12 | 1.7 ± 0.77 | 40.3 ± 0.57 | 1.3 ± 0.77 | 587 | 100 |
rApxIVA | 3 | 2.6 ± 0.5 | 40.8 ± 0.4 | 1.8 ± 0.5 | 100 | 100 |
rTbpB | 3 | 2.7 ± 0.5 | 40.9 ± 0.5 | 1.9 ± 0.7 | 100 | 100 |
rApxIA+rApxIIA+rApxIIIA | 3 | 1.9 ± 0.7 | 40.5 ± 0.4 | 1.5 ± 0.6 | 100 | 100 |
rApxIA+rApxIIA+rApxIIIA+rApxIVA+rTbpB | 7 | 1.2 ± 0.57 | 39.9 ± 0.47 | 1.0 ± 0.67 | 86 | 100 |
rApfA+rApxIA+rApxIIA+rApxIIIA+rApxIVA+rTbpB | 7 | 0.3 ± 0.57,8 | 39.6 ± 0.57 | 0.3 ± 0.57,8 | 297 | 100 |
Control (PBS in oil adjuvant) | 7 | 3.2 ± 0.7 | 41.2 ± 0.4 | 2.3 ± 0.7 | 100 | 57 |
Non-treated | 2 | 0 | 39.1 ± 0.4 | 0 | 0 | 100 |